Table of Content


Table of Contents

 

1) T-Cell Redirecting Bispecific Antibodies

 

  • Targeting BCMA

  • Targeting CD20

  • Targeting CD19

  • Targeting CD33

  • Targeting CD123

  • argeting PSMA

  • Targeting Her2

  • Targeting Mesothelin

  • Targeting CD38

  • Targeting EGF-R

  • Targeting DLL3

  • Targeting Various Other Cancer Surface Antigens

  • Targeting Not Disclosed Tumor Associated Antigens

  • Targeting (Intracellular) peptide/MHC Antigens

  • Novel Bispecific T-Cell Redirecting Antibody Constructs

  • Bispecific T-Cell Redirecting Antibodies for Infectious & Other Diseases


  •  
 

2) Bispecific Natural Killer (NK) Cell Redirecting Antibodies

3) Bispecific T-Cell Engaging, Conditional Costimulatory Antibodies

 

  • Bispecific, Tumor-Targeted, Conditional 4-1BB Costimulatory Antibodies

  • Bispecific, Tumor-Targeted, Conditional CD40 Costimulatory Antibodies

  • Bispecific, Tumor-Targeted, Conditional CD28 or OX40 Costimulatory Antibodies

  • Bispecific, Dual Costimulatory Antibodies


  •  
 

4) Bispecific Immuno-Oncology Antibodies

 

  • Bispecific, Tumor-Targeted Checkpoint Inhibitor Antibodies

  • Bispecific Checkpoint Inhibitor & Costimulator Antibodies

  • Bispecific CD47 Tumor Microenvironment (TME) Targeted Antibodies

  • Other Bispecific, Tumor Microenvironment (TME) Targeted Antibodies

  • Bispecific, Dual PD-1 & PD-L1 Checkpoint Inhibitor Antibodies

  • Bispecific, Dual PD-1/PD-L1 & CTLA-4 Checkpoint Inhibitor Antibodies

  • Bispecific, Dual PD-1 & LAG-3 Checkpoint Inhibitor Antibodies

  • Bispecific, Dual PD-L1/CTLA-4 & LAG-3 Checkpoint Inhibitor Antibodies

  • Bispecific, PD-1/PD-L1/CTLA-4 & TIM-3 or GITR Checkpoint Inhibitor Antibodies

  • Bispecific, Not Specified Immuno-Oncology Antibodies


  •  
 

5) Bispecific Tumor Associated Antigen (TAA) / Growth Factor Targeted Antibodies –

 

  • Bispecific Her2-Targeted Antibodies

  • Bispecific VEGF-Targeted Antibodies

  • Other Bispecific TAA-Targeted Antibodies


  •  
 

6) Bispecific Antibodies for Non-Cancer Indications

 

  • Bispecific Inflammatory & Autoimmune Disease Antibodies

  • Bispecific Cardiometabolic Antibodies

  • Bispecific Ophthalmic Disease Antibodies

  • Bispecific Neurologic Disease Antibodies

  • Bispecific Infectious Disease Antibodies

  • Bispecific Antibodies For Targeted Delivery


  •